Devices that inject electrical signals directly into nerves may soon restore movement to people who have lost the use of an arm or leg.
Read Full Article at New Scientist - Paralysed limbs revived by hacking into nerves
Showing posts with label Business. Show all posts
Showing posts with label Business. Show all posts
Saturday, April 3, 2010
Saturday, March 27, 2010
One of the better-kept secrets about the massive clinical research hospital at the National Institutes of Health (NIH) in Bethesda, Md., has been tucked away for half a century in Wing D of a building that dates to 1953. That is about to change.
The Pharmaceutical Development Section (PDS) is a corps of 20 chemists, pharmacists, pharmacokineticists and technicians who make investigational agents for many of the 1,500 clinical research studies running at any given moment at the NIH's Clinical Center. It is not a drug-discovery group, but rather a team of experts who churn out custom-made pills, vaccines, intravenous drugs and capsules, and even ointments and creams, for NIH investigators when the investigational agents they need aren't available.
Twenty-first century technology and government-mandated manufacturing standards have outpaced the equipment and capacities of the group's old, 743-square-metre workspace. But, if all goes according to schedule, in early June it will move seamlessly into a new, $12-million, 1,115-square-meter drug-making facility--a warren of rooms seven years in the planning that is tailor-made for the group's purposes.
The PDS's new digs are a reservoir of state-of-the-art machinery and minus 80 ºC freezers; high-efficiency particulate-absorbing filters populate the ceiling; and highly purified watercirculates through stainless-steel pipes that cost over $1,000 per meter. There are meticulous controls on air temperature, humidity and pressure. The facility's layout and structural materials are geared to maximum cleanliness--right down to the easily-scoured, porous epoxy floors."
Sunday, March 14, 2010
Miami's Phillip Frost to head generic drugmaker - Business - MiamiHerald.com
Phillip Frost, a Miami physician-entrepreneur, was chosen as chairman by generic drug giant Teva.
Generic drugmaker Teva Pharmaceutical Industries said Tuesday it has appointed Vice Chairman Dr. Phillip Frost to serve as chairman of its board. The world's largest generic drugmaker by revenue said Frost, a Miami physician-entrepreneur, will replace Moshe Many, who had been serving as interim chairman and will now serve as vice chairman.
Frost, a dermatologist, has developed and sold two major Miami healthcare companies. He took over Key Pharmaceuticals in 1972 and sold the firm to Schering-Plough in 1986 for $600 million. Frost pocketed $100 million from the deal.
In 1987 he started Ivax, which Teva purchased in 2006 for $7.6 billion, which earned Frost $1.2 billion in cash and stock. Frost had served as vice chairman of Teva's board since 2006. He also serves as chairman and CEO of Opko Health, a specialty pharmaceutical company, and as chairman of Ladenburg Thalmann Financial Services, both Miami companies, and Prolor Biotech, which is based in Israel.
Miami's Phillip Frost to head generic drugmaker - MiamiHerald.com
Wednesday, October 14, 2009
Biotech firm settles in Jupiter
One of its four founders is Nobel laureate Paul Greengard. A neuorscience professor at Rockefeller University in New York, Greengard shared the 2000 Nobel Prize in Physiology or Medicine with two others for discovering how dopamine, among other things, affects the nervous system.
Envoy's Web site said it will try to develop drugs for schizophrenia, Parkinson's, Alzheimer's, drug addiction, epilepsy, anxiety and depression and other disorders. The research will focus on identifying proteins in the brain that can be targeted by new drugs.
"They have a way of dealing with individual brain cell genes," said Richard Lerner, president of The Scripps Research Institute. "They find proteins produced in very specialized areas of the brain."
Biotech firm settles in Jupiter
![Reblog this post [with Zemanta]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sZMR4qqdnAEqum3odvkmXS1NvyGY_m86Zw8qNxDGYlyyjY8qKIl9jmymW4ECMcY_mVSB2yhBCq_NQ73WTnZYBLxldsv1h9ULWpz_dSE3bCMjVZX1qgYSeHiqWSOeixDULm4A82zBsFW7IEf80lHOGb=s0-d)
Subscribe to:
Posts (Atom)
Posts
